A32 Evaluation of the Mutant KRAS-Driven NSCLC Tumor Immune Microenvironment Using Patient-Derived Cell Line Xenografts in a Humanized Mouse Preclinical Model for Development of New Immunotherapy Approaches
Year: 2020
Type: conference-abstract
Source: Journal of Thoracic Oncology
Institution: The University of Texas Southwestern Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3001790992